Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies
Exclusive Agreement for Rabies Monoclonal Antibodies to Fight Fatal Disease LYON, France, January 3 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive collaboration and commercialization agreement with Crucell ...Group B Strep Screening Guidelines Sparing Newborns
...rresponded with further declines in the incidence of early-onset GBS [group B strep] disease." Van Dyke is now an epidemiologist at GlaxoSmithKline biologicals in Rixensart, Belgium, although that company played no part in this study, which appears in the June 18 issue of the New England Journal of Medicine ...3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis
... chronic arthritis in children, frequently results in physical disabilities and chronic pain influencing daily life. The results for the Arthritis and biologicals in Children project show impressive improvement on all domains of Health-Related Quality of Life impaired by JIA during treatment with etanercept. Thi...Senate Bill to Protect Patients' Healthcare by Amending Medicare Coverage
...e-saving cancer treatments." This bill will amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program. It excludes customary prompt pay discounts extended to wholesalers from the manufacturer's Average Sales Price ...Dieter Luetticken Award 2008 Recognizes Development of New Vaccine Quality Control Assay
...of laboratory animals as well as studies aimed at reducing or avoiding the use of animals in efficacy, safety and quality testing in the production of biologicals and pharmaceuticals for animals. The award is named after Dr. Dieter Luetticken, a committed researcher in microbiology and virology. He has guid...EXT Life Sciences Announces New Biotech Treatment that Tackles Root Cause of Graying Hair
... EXT is a Michigan-based biotechnology company engaged in developing, manufacturing, and selling new classes of proprietary, targeted antioxidant biologicals to prevent, treat and cure diseases associated with aging in the global pharmaceutical and cosmeceutical markets. EXT, founded in 2004, was initially...Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center
...School of Medicine. "The future treatments for advanced lung cancer may involve combinations of chemotherapy and targeted agents, and possibly even biologicals such as this," she said. Roughly 430 patients die of lung cancer every day in the United States, according to Bazhenova, making it the nation's nu...Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet
... Clinical R&D and Chief Medical Officer of GSK biologicals commented: "These excellent study results confirm ...to detect through screening. GlaxoSmithKline biologicals -- GSK Biologicals, GlaxoSmithKline's vaccines ...more in development. Headquartered in Belgium, GSK biologicals has 13 manufacturing sites strategically positione...Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference
...he mosquito-borne malaria parasite. "These are all tools that need to be used together," he said. The RTS,S vaccine, developed by GlaxoSmithKline biologicals with support from the Malaria Vaccine Initiative of PATH (Program for Appropriate Technology in Health), is the first of 70 experimental malaria vacci...GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
...any information, please visit http://www.gsk.com/media . GlaxoSmithKline biologicals (GSK Biologicals) is a leading global vaccine manufacturer committed to pre...ccines currently available globally and 20 more in development. In 2007 GSK biologicals distributed 1.1 billion doses of vaccines -- an average of 3 million doses ...CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
...lity of human life by enabling people to do more, feel better and live longer. For company information, please visit http://www.gsk.com/media . GSK biologicals (GSK Bio), one of the world's leading vaccine manufacturers, is headquartered in Rixensart, Belgium, where the majority of GlaxoSmithKline's activitie...VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week
...9th "Vaccine Renaissance," 8:30-10:00 am, Room 29A including Dr. Robert Becker "Moore's Law for Biomanufacturing: Innovation in a Maturing biologicals Industry," 4:00 - 5:30 pm, Room 29B including Edward Arcuri, PhD, VaxInnate's Chief of Operations (COO) VaxInnate's Approach VaxInnate's n...Novavax Reports Second Quarter 2009 Financial Results
...hich is targeted for 2012. Raised $21.9 million from the sale of 7.4 million shares of common stock through the ATM program. Launched CPL biologicals Pvt. Ltd, the previously announced joint venture with Cadila Pharmaceuticals, to develop and manufacture vaccines, biological therapeutics and diagnos...Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
...ies in March 2009. This joint venture, called CPL biologicals Pvt. Ltd., will develop and manufacture vaccines, ...avax and Cadila Pharmaceuticals. In addition, CPL biologicals will establish manufacturing facilities in India a...virus-like-particle (VLP) vaccine technology. CPL biologicals also expects to develop the pandemic H1N1 influenz...AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS
...tal of euro 11.5 million. Without this capital, our licensing deal with GSK biologicals three years later would not have been possible. This deal is for up to euro... studies. In October 2008, the company succeeded in gaining GlaxoSmithKline biologicals as its licensing partner for the Alzheimer's vaccine. The contract anticipa...AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
...censing agreement worth EUR 430 million that we recently concluded with GSK biologicals regarding the rights for the technology for our Alzheimer's vaccine program... studies. In October 2008, the company succeeded in gaining GlaxoSmithKline biologicals as its licensing partner for the Alzheimer's vaccine. The contract foresees...Pharma and Biotech Companies Plug into Singapore's Integrated Research Network
...panies to test and develop new solutions for Asia and beyond. Recent announcements of public-private partnerships (PPP) include GlaxoSmithKline biologicals committing US$1.3 million in vaccine and process development with Singapore's Bioprocessing Technology Institute (BTI); Lilly Singapore Centre for Dru...Caliper Life Sciences Reports First Quarter 2009 Results
... of the proprietary LabChip GX, which the Company believes is the "best-in-class" proprietary solution for characterizing proteins in the fast growing biologicals market, and increased sales of Profiler Pro reagent kits which are used for kinase screening with the EZ Reader instrument. Optical Imagin...CERVARIX(R) U.S. Regulatory Update
...erous lesions are diagnosed. GlaxoSmithKline biologicals - GSK's vaccines business is one of the world's l...more in development. Headquartered in Belgium, GSK biologicals has 13 manufacturing sites strategically positioned around the globe. In 2008 GSK biologicals distributed 1.1 billion doses of vaccines to 176 c...Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG
...y technology by a major oncology company," said Christian Itin, Micromet's Chief Executive Officer. "Oncology is one of our core growth areas and biologicals are a key focus of our strategy. We are excited about Micromet's BiTE antibody technology and believe BiTE antibodies represent a novel and promising...Rabbit Anti-HPRT Polyclonal Antibody, Unconjugated from Novus Biologicals
Description: ...Mouse Anti-hnRNP F / H Monoclonal Antibody, Unconjugated, Clone 1G11 from Novus Biologicals
Description: ...Rabbit Anti-Human Histone H3, acetyl Polyclonal Antibody, Unconjugated from Lake Placid Biologicals
Description: Antibody specific for histone H3 acetylated at any of the five N-terminal lysine residues. Rabbit polyclonal serum. Antigen: Synthetic peptide derived from histone H3 N-terminal region, mulitpliy acetylated...Rat Complement from Pel-Freez Biologicals
Description: Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ice bath, bottled, and frozen at -70C....Pig Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
Description: Whole blood is collected from healthy pigs (mixed breed, either sex) at the time of slaughter, refrigerated within 6 hours, processed within 24 hours and frozen at -20ºC....Rat Serum Non-Sterile Non-Hemolyzed from Pel-Freez Biologicals
Description: Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is later thawed, pooled, bottled and frozen at -20?C....Dog Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
Description: Whole blood is collected from canines (any breed, either sex), refrigerated within 6 hours, processed within 24 hours and frozen at -20C....Rat Serum Non-Sterile Trace-Hemolyzed from Pel-Freez Biologicals
Description: Rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and refrigerated within 6 hours, and processed and frozen within 24 hours. The serum is later thawed, pooled, bottled and frozen at -20?C....